Insulin aspart, recombinant Subcutaneous and Rubella virus vaccine, live Subcutaneous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Rubella virus vaccine, live Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: rubella virus vaccine
Brand name:
Synonyms: Rubella virus vaccine, live (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Rubex
- Insulin aspart, recombinant Subcutaneous-Rubraca
- Insulin aspart, recombinant Subcutaneous-Rubramin PC
- Insulin aspart, recombinant Subcutaneous-Rucaparib
- Insulin aspart, recombinant Subcutaneous-Rucaparib Camsylate
- Insulin aspart, recombinant Subcutaneous-Ruconest
- Rubella virus vaccine, live Subcutaneous-Insulin degludec
- Rubella virus vaccine, live Subcutaneous-Insulin Degludec (U-100) Prefilled Pens
- Rubella virus vaccine, live Subcutaneous-Insulin Degludec (U-100) Vials
- Rubella virus vaccine, live Subcutaneous-Insulin Degludec (U-200) Prefilled Pens
- Rubella virus vaccine, live Subcutaneous-Insulin degludec and liraglutide
- Rubella virus vaccine, live Subcutaneous-Insulin degludec and liraglutide Subcutaneous